GlassScriptPhysician profile
Allison Boden
NPI 1932604402
$11,828.44
in general payments reported to CMS, 2019-2025
21 companies · $2,569 in 2025
The $2,569 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $855 · 2023: $4,650 · 2024: $3,557 · 2025: $2,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,891 · Travel and Lodging: $3,492 · Long Term Medical Supply Or Device Loan: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,891.46 |
| Travel and Lodging | $3,492.08 |
| Long Term Medical Supply Or Device Loan | $392.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,703.31 | 2022-2025 | Inbone, Mako, Infinity Adaptis |
| Smith+Nephew, INC. | $1,443.21 | 2023 | Evos, Trigen |
| Medline Industries LP | $1,356.19 | 2024-2025 | |
| Arthrex, INC. | $968.59 | 2021-2025 | |
| Blue Surgical LLC | $779.99 | 2024-2025 | |
| Suvon Surgical LLC | $559.78 | 2023-2024 | |
| Orthofix Medical, INC. | $404.09 | 2024-2025 | Truelok, Trinity Elite, Physio-Stim |
| Integra Lifesciences Corporation | $392.07 | 2025 | Micromatrix |
| Linvatec Corporation | $198.23 | 2024-2025 | Biobrace 23mm |
| Medtronic, INC. | $174.15 | 2021-2025 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $122.62 | 2025 | |
| Fusion Orthopedics USA, LLC | $121.12 | 2025 | |
| Next Science LLC | $117.27 | 2025 | Blastx, Xperience |
| Exactech, INC. | $116.96 | 2023 | |
| Cerapedics INC. | $115.31 | 2025 | I-Factor Peptide Enhanced Bone Graft |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $102.72 | 2025 | Magellan |
| Ferring Pharmaceuticals INC. | $39.40 | 2025 | Euflexxa |
| Amgen INC. | $33.29 | 2025 | Evenity |
| Anika Therapeutics, INC. | $28.57 | 2024 | Integrity |
| Bioventus LLC | $27.65 | 2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $23.92 | 2023 | Znn |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Boden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.